Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS

Talking Therapeutics

Fishing for Further Reductions in Residual Cardiovascular Risk

03/31/2021

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

Dr Jennings reviews two of the latest trials evaluating the controversial topic of fish oils products, and attempts to get the bottom of this murky pond of conflicted evidence.

Dr Jennings reviews two of the...

03/31/2021

Pharmacy Learning Network

Talking Therapeutics

Straight Talk on COVID-19 Farses

01/19/2022

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

In this week's issue of Talking Therapeutics, Dr Jennings discusses COVID-19 misinformation, how it could impact patient health and industry costs, and how pharmacists can combat it.

In this week's issue of Talking...

01/19/2022

Pharmacy Learning Network

Talking Therapeutics

ACC.22 Update Part 2: Influenza Vaccines, EHR Alerts, PCSK9 Inhibitors

04/14/2022

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

Dr Jennings returns with another ACC.22 round up, including new research on influenza vaccines, electronic health record alerts for providers, and more.

Dr Jennings returns with another...

04/14/2022

Pharmacy Learning Network

Talking Therapeutics

AHA Scientific Sessions 2022 Update, Part 2: The Diuretic Wars

11/17/2022

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

In the second part of his coverage of AHA Scientific Sessions 2022, Dr Jennings shares 2 randomized trials designed to compare diuretics for the treatment of hypertension and heart failure.

In the second part of his...

11/17/2022

Pharmacy Learning Network

Talking Therapeutics

Time to Discontinue Levothyroxine for Heart Organ Donors

12/04/2023

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

In this week’s installment of Talking Therapeutics, Dr Jennings evaluates a recent randomized trial to address how hormone deficiency can lead to myocardial energy depletion and subsequent decline in cardiac function in donor recipients.

In this week’s installment of...

12/04/2023

Pharmacy Learning Network

Talking Therapeutics

Take It Slow or Move to the Rhythm?

08/18/2021

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

In this week’s edition of Talking Therapeutics, Dr Jennings explores the latest clinical trial data comparing rhythm-control strategy vs usual care for the treatment of patients with atrial fibrillation.

In this week’s edition of...

08/18/2021

Pharmacy Learning Network

Talking Therapeutics

Is Hydroxychloroquine Harmful for the Heart?

06/30/2022

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

In the latest installment of Talking Therapeutics, Dr Jennings discusses possible adverse events associated with hydroxychloroquine.

In the latest installment of...

06/30/2022

Pharmacy Learning Network

Talking Therapeutics

More Evidence of Cardiovascular Harm With NSAIDs

04/13/2023

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

In light of a new study, Dr Jennings advocates for practicing pharmacists to discuss the potential cardiovascular harm associated with short-term use of nonsteroidal anti-inflammatory drugs.

In light of a new study, Dr...

04/13/2023

Pharmacy Learning Network

Talking Therapeutics

Contraindications Associated With Combining Amiodarone and Rivaroxaban

04/08/2024

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

In this installment of Talking Therapeutics, Dr Jennings examines the interactions between amiodarone and rivaroxaban for patients under prescription, outlining crucial considerations for prescribers when administering these medications to...

In this installment of Talking...

04/08/2024

Pharmacy Learning Network

Talking Therapeutics

COVID-19 Catchup: New Pills, Steroid Dosing

11/10/2021

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

In the wake of recent research and news, Dr Jennings discusses the efficacy and safety of two COVID-19 pills, as well as corticosteroid dosing for patients with hypoxemia.

In the wake of recent research...

11/10/2021

Pharmacy Learning Network